Anika Therapeutics Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ANIK Nasdaq 2834 https://www.anikatherapeutics.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Anika Therapeutics Inc

Ultragenyx & Arcturus Therapeutics Expand Existing Agreement - Jun 20th, 2019 7:01 am
Alexion's (ALXN) Ultomiris Gets Approval in Japan for PNH - Jun 19th, 2019 2:07 pm
Arena Initiates Dosing in Pivotal Colitis Study on Etrasimod - Jun 18th, 2019 8:38 am
Alnylam Completes Enrollment in Phase III Study of Lumasiran - Jun 18th, 2019 7:58 am
Alexion's (ALXN) PNH Drug Ultomiris Shows Long-Term Efficacy - Jun 17th, 2019 4:17 pm
Dr. Reddy's Inks Deal to Sell Neurology Branded Products - Jun 14th, 2019 3:25 pm
Catalyst Pharma Files Lawsuit Against FDA Approval of Ruzurgi - Jun 13th, 2019 3:46 pm
Alkermes Initiates Monothearpy Expansion Phase of ALKS 4230 - Jun 13th, 2019 8:26 am
Are Insiders Selling Anika Therapeutics, Inc. (NASDAQ:ANIK) Stock? - Jun 12th, 2019 1:51 pm
Zynerba Up on Second Patent for Cannabidiol Candidate in 2019 - Jun 12th, 2019 7:39 am
Novavax' Shares Drop as FDA Advises Another Study for Resvax - Jun 11th, 2019 4:18 pm
Dr. Reddy's Reports Positive Top-Line Data on Psoriasis Drug - Jun 10th, 2019 3:30 pm
Incyte Begins Phase III Study for Treatment of Duct Cancer - Jun 6th, 2019 1:26 pm
Anika Announces Plans to Showcase HYALOFAST Hyaluronic Acid-Based Cartilage Repair Scaffold at the 2019 International Cartilage Regeneration and Joint Preservation Society (ICRS) Focus Meeting - Jun 5th, 2019 6:00 am
bluebird's Zynteglo Gets EU Conditional Marketing Approval - Jun 4th, 2019 2:16 pm
Celldex Presents Data From CDX-3379 Study at ASCO, Stock Down - Jun 4th, 2019 8:26 am
uniQure (QURE) Jumps: Stock Rises 8.9% - Jun 4th, 2019 7:01 am
Alnylam Initiates Phase I Study on Hypertension Candidate - Jun 3rd, 2019 2:48 pm
Fibrocell Up on FDA Designation for Gene Therapy Candidate - May 30th, 2019 6:44 am
Amarin Rises on Priority Review for Vascepa Label Expansion - May 30th, 2019 6:28 am